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Scientific Note
Abstract
Rapidly advancing technology provides successive generations of irradiation techniques and modalities of cancer treatment in
radiation oncology. Most of these techniques are able to deliver higher doses per fraction than the standard 2 Gy per day. The
complexity of these new techniques involves hundreds of parameters for the delivery of each beam making quality assurance
increasingly demanding. A direct assessment of the "final product", namely the absorbed dose, would be extremely useful if easy
to obtain. Thus, a real need exists for dosimeters able to provide direct and real time measurements within the target volume.
Nanotechnology is a relatively new field, and in some ways raises new technological aspirations, especially in the field of
medical applications for cancer treatment. In this paper we argue the need for an implantable “nano-dosimeter” based on
nanotechnology to monitor the delivered dose, combining all the ideal features such a future tool should have for quality
assurance in radiation oncology.
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Radiation therapy modalities
Radiation therapy techniques can be divided in four main
types: external beam radiotherapy (EBRT), brachytherapy,
intra-Operatory Radiation Therapy (IORT) and metabolic
radiation therapy. In EBRT there are numerous different
machines, all using compact linear accelerators applying
several techniques, such as three-dimensional radiation
therapy (3DRT), intensity-modulated radiation therapy
(IMRT), volumetric-modulated arc therapy (VMAT), Tomo-
therapy, Stereotactic RT, etc. In addition to these X-ray
based techniques one should also mention hadron therapy
(mainly with protons and low atomic weight ions). Usually
the total prescribed dose is delivered in several fractions,
with a typical fraction of 2 Gy per day. Treatments often last
well over one month with 5 fractions a week. The reason is
the time necessary for the repair and regrowth of normal
cells to allow an acceptable treatment tolerance for sur-
rounding healthy tissues. Advanced techniques like VMAT
may require shorter delivery times and can even be delivered
as hypo-fractionated courses increasing the dose per fraction
(above 2 Gy) and decreasing the number of fractions. Stere-
otactic RT, for small volumes, is pushing this very far by
delivering up to 6 to 25 Gy in few or even one unique frac-
tion. Beside the economic aspects, the hypo-fractionated
approach is justified by the fact that small doses per fraction
are also less efficient on tumors. When anatomical and bal-
listic conditions restrict irradiation to almost only the tumor
volume, a reduction of the fractionation is possible and im-
proves the dose-effect on the tumor. However, this requires
very high precision and demands ensuring the perfect
achievement of each session by monitoring the deposited
dose by an appropriate means, if possible in real time to al-
low immediate correction when needed.
Dosimetry for quality assurance in irradiation
therapy: state of the art
To really improve quality assurance in radiation therapy, it is
desirable to implement in-vivo real time measurement de-
vices, such as miniature dosimeters. The objective is to ensure
that the measured dose meets the prescribed dose. A change
of 5% in the delivered dose can result in a 10 to 20% change
in the local tumor control probability (TCP) and have up to a
30% impact in normal tissue complication probability
(NTCP).1 However, the real clinical consequences of such
deviations in the dose are modulated by the position of the
dose level in the TCP and NTCP curves.2 Despite several
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existing technologies such as small ionization chambers,
silicon diodes, metal-oxide semiconductor field effect tran-
sistor (MOSFET), thermo-luminescent dosimeter (TLD),
optically stimulated luminescence (OSL), diamond and films,
none are completely suitable for real time in-vivo measure-
ments.3 The principle of detection of these dosimeters can be
categorized into 4 types: air cavity, semiconductor, solid
state and chemical, as shown in Figure 1. Ionization cham-
bers are used to calibrate the linear accelerator and are not
used as in-vivo dosimeters. The other types of dosimeters can
be used for in-vivo measurements and can be classified ac-
cording to the site of measurements, either external or in-
ternal:
Type (a): dosimeters for entry dose measurements such as
diodes, TLD, films, etc. Since about a decade this type of
“in-vivo dosimetry” has been used to measure the entry dose
with dosimeters placed in the site where the beam penetrates
the patient’s skin. This method has been adapted for standard
fractions of less than 2Gy per session per beam.
Type (b): implantable dosimeters for measurements within
the target volume including the tumor or organs at risk, such
as MOSFET and solid state crystals (GaN; Al2O3/C). These so
called, "implantable" dosimeters can be somehow introduced
into the body either via natural cavities or, less frequently,
directly into the tissues.
FIG. 1: Classification of dosimeters for dose measurements in radiation oncology.
FIG. 2: Examples of external and implantable dosimeters for real time measurements. (a) The dosimeter from
(b) MOSFET from Sciel technologies® (Raleigh, NC), Al2O3/C from http://medicalphysicsweb.org and the GaN probe from Chaikh et al. 2014.
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Implantable dosimeters based on macro/micro
detectors for real time measurements
The use of implantable dosimeters for monitoring the deliv-
ered dose has undergone some progress in the last few years.
For example, the dose verification system from Sciel tech-
nologies® (Raleigh, NC) based on an implantable MOSFET
dosimeter is already quite small (20 × 2.1 mm) 4, Figure 1.
Recently OSL dosimeters such as carbon-doped aluminium
oxide (Al2O3/C) have been improved and are proposed as
implantable dosimeters for brachytherapy.5 More recently, a
Gallium Nitride (GaN) based implantable dosimeter for real
time measurements has been developed (Figure 2).6 The
prototype includes a tiny GaN crystal (< 0.1 mm3) coupled
with an optical fiber of external diameter 0.9 mm. GaN is a
very efficient radioluminescent direct gap semiconductor.
The GaN dosimeter is connected to a laptop equipped with a
photo-multiplier. It offers interesting advantages for clinical
use such as small size, radiation robustness and no chemical
toxicity. The sensor has been calibrated but as yet few clini-
cal studies have been performed.
FIG. 3: A three channel bladder drain equipped with a GaN probe:
the 3 channels are the following: drain, balloon inflation and GaN
dosimeter probe insertion.
FIG. 4: Two suggested examples of the implantation of a dosimeter
for pelvic cancer including prostate (left panel) and uterine cervix
(right panel).
Advantages, requirements and limitations
The current implantable dosimeters have various advantages
and limitations. The advantage of using an optical fiber cou-
pled with a radio luminescent crystal is its ability to be im-
planted into, and retrieved from, a patient. This device can
be inserted into natural cavities such as the rectum, head and
neck cavities, or the bladder, using catheters, for example a
bladder drain with a balloon, as shown in Figure 3. This re-
quires a catheter having three channels: one for draining,
one for inflating the balloon and one for inserting the optical
fiber carrying the dosimeter. Such catheters currently exist
for bladder hemorrhage washing. Figure 4 suggests possible
applications of the GaN dosimeter for gynecological cancer
using a device inserted into the bladder and for prostate
cancer by way of an interstitial implantation into the peri-
neum. However, most of these dosimeters need either elec-
trical or optical connections; otherwise the dosimeter be-
comes rather large if it has to include wireless transmission
technology. Moreover, optical fibers produce Cerenkov light,
which must be eliminated, and needs shielding optical con-
nections, a critical point.2
Perspectives and new concepts
As mentioned above, recent progress in radiotherapy tech-
nologies make it more and more possible to deliver higher
doses over shorter times and fewer sessions. This makes each
irradiation session more critical than previously. Thus, the
opportunity to verify in real time the realization of each
session is highly desirable to ensure the exact delivery of the
planned treatment. The use of an implantable dosimeter
appears to be an interesting solution; however present tech-
niques have many drawbacks.
Further progress is necessary. The ideal dosimeter should
have a very small size (on a nanometer scale), be easy to im-
plant into the patient for real time in-situ dose measure-
ments, have a low cost, be able to transmit the data via wire-
less communications, have no toxicity for the tissue and,
why not, be resorbable. In terms of physical properties it
should also have no energy or angular dependence, and not
perturb the delivered dose. To our knowledge such a device
is as yet far from existing.
The size of a nano detector is a critical point, because the size
of a dosimeter must respect two criteria: firstly it should be
large enough to detect enough events to produce a statisti-
cally reproducible measure of the dose in the range of ex-
pected use (in terms of type of beam and dose rate), and sec-
ondly it should be held in the tissues at the desired point
within the target volume and not be displaced or removed by
blood-flow or tissue movement due to pressure. M Beuve
(2009) showed, using Monte Carlo simulation, that the local
dose can be represented using a sensitive volume as large as
10 µm in size in order to reduce significantly the statistical
fluctuations in energy deposition, which could be deleterious
for volumes as small as 10 nm.7, 8
The main role for such a nano dosimeter would be to moni-
tor the delivered dose for target volumes that include the
tumor and organs at risk. One could imagine implanting a set
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of such devices at the most critical sites. Recently considera-
ble progress has been made in the technology of nano mate-
rials and they are being integrated into medical applications
for surgery, therapy, diagnostics, imaging and cancer treat-
ments. We foresee that in the near future nano-technologies
will enable us to produce nano-dosimeters based on nano
materials.
Conclusion
The treatment of cancer using radiation therapy uses various
modalities. Current techniques are becoming more and more
sophisticated and can deliver higher doses per fraction in
fewer fractions, giving the possibility to maximize the deliv-
ered dose to the tumor and to minimize the dose to sur-
rounding tissues. Therefore the risk of inadequate or injuri-
ous sessions is an increasing challenge for optimal quality
insurance. One solution could be the use of nanotechnology
to provide new devices to monitor and measure the deliv-
ered dose in real time inside the target itself.
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